{"id":"NCT01100307","sponsor":"Pfizer","briefTitle":"A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema","officialTitle":"A Phase 3, Randomized, Controlled, Double-Masked, Multi-Center, Comparative, In Parallel Groups (For 24 Weeks), To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium, With Sham Injections, And Open Study (For 30 Weeks) To Confirm The Safety Of 0.3 MG Pegaptanib Sodium In Subjects With Diabetic Macular Edema (DME)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-05","primaryCompletion":"2012-08","completion":"2012-08","firstPosted":"2010-04-08","resultsPosted":"2013-07-15","lastUpdate":"2013-08-23"},"enrollment":243,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Macular Edema","Diabetic Mellitus","Retinal Disease"],"interventions":[{"type":"DRUG","name":"pegaptanib sodium","otherNames":[]},{"type":"OTHER","name":"sham injection","otherNames":[]}],"arms":[{"label":"pegaptanib sodium","type":"EXPERIMENTAL"},{"label":"sham injection","type":"SHAM_COMPARATOR"}],"summary":"The purpose of the study to assess the efficacy of pegaptanib sodium 0.3 mg comparing sham injection and to confirm safety of pegaptanib sodium 0.3 mg in subjects with diabetic macular edema.","primaryOutcome":{"measure":"Number of Participants Who Experience a â‰¥10 Letter Improvement of Visual Acuity (VA) in Early Treatment Diabetic Retinopathy Study (ETDRS) Chart From Baseline at Week 24: Double Masked Phase","timeFrame":"Baseline and Week 24","effectByArm":[{"arm":"Pegaptanib Sodium","deltaMin":25,"sd":null},{"arm":"Sham in Double Masked, Then Pegaptanib Sodium in Open Phase","deltaMin":6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0003"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":43,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A5751034&StudyName=A%20Phase%203%20Study%20To%20Compare%20The%20Efficacy%20And%20Safety%20Of%200.3%20MG%20Pegaptanib%20Sodium%20To%20Sham%20Injections%20In%20Subjects%20With%20Diabetic%20Macula"]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":123},"commonTop":["Conjunctival Haemorrhage","Nasopharyngitis","Punctate Keratitis","Conjunctival Oedema","Intraocular Pressure Increased"]}}